2qri Citations

Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Chem Biol 14 909-22 (2007)
Related entries: 2qrs, 2qrt

Cited: 39 times
EuropePMC logo PMID: 17719490

Abstract

MHC class I peptide complexes (pMHC) are routinely used to enumerate T cell populations and are currently being evaluated as vaccines to tumors and specific pathogens. Herein, we describe the structures of three generations of single-chain pMHC progressively designed for the optimal presentation of covalently associated epitopes. Our ultimate design employs a versatile disulfide trap between an invariant MHC residue and a short C-terminal peptide extension. This general strategy is nondisruptive of native pMHC conformation and T cell receptor engagement. Indeed, cell-surface-expressed MHC complexes with disulfide-trapped epitopes are refractory to peptide exchange, suggesting they will make safe and effective vaccines. Furthermore, we find that disulfide-trap stabilized, recombinant pMHC reagents reliably detect polyclonal CD8 T cell populations as proficiently as conventional reagents and are thus well suited to monitor or modulate immune responses during pathogenesis.

Reviews - 2qri mentioned but not cited (1)

  1. Properties and applications of single-chain major histocompatibility complex class I molecules. Kotsiou E, Brzostek J, Gould KG. Antioxid Redox Signal 15 645-655 (2011)

Articles - 2qri mentioned but not cited (1)



Reviews citing this publication (2)

  1. Basic and translational applications of engineered MHC class I proteins. Hansen TH, Connolly JM, Gould KG, Fremont DH. Trends Immunol 31 363-369 (2010)
  2. T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy. Duan Z, Ho M. Mol Cancer Ther 20 1533-1541 (2021)

Articles citing this publication (35)